Alexanian, Michael https://orcid.org/0000-0001-6224-6354
Padmanabhan, Arun
Nishino, Tomohiro https://orcid.org/0000-0002-3593-7368
Travers, Joshua G. https://orcid.org/0000-0002-5660-2620
Ye, Lin https://orcid.org/0000-0001-7351-8685
Pelonero, Angelo
Lee, Clara Youngna https://orcid.org/0000-0002-9402-4155
Sadagopan, Nandhini
Huang, Yu
Auclair, Kirsten
Zhu, Ada
An, Yuqian
Ekstrand, Christina A. https://orcid.org/0009-0004-5182-3573
Martinez, Cassandra
Teran, Barbara Gonzalez
Flanigan, Will R. https://orcid.org/0000-0001-5900-3490
Kim, Charis Kee-Seon https://orcid.org/0000-0002-8344-7865
Lumbao-Conradson, Koya
Gardner, Zachary https://orcid.org/0000-0003-1905-8686
Li, Li
Costa, Mauro W. https://orcid.org/0000-0003-3579-8625
Jain, Rajan https://orcid.org/0000-0002-1979-044X
Charo, Israel
Combes, Alexis J. https://orcid.org/0000-0002-9110-6542
Haldar, Saptarsi M.
Pollard, Katherine S.
Vagnozzi, Ronald J. https://orcid.org/0000-0002-8027-1809
McKinsey, Timothy A.
Przytycki, Pawel F. https://orcid.org/0000-0002-3360-6936
Srivastava, Deepak
Article History
Received: 21 December 2022
Accepted: 19 September 2024
First Online: 23 October 2024
Competing interests
: D.S. is scientific co-founder, shareholder and director of Tenaya Therapeutics. S.M.H. is an executive, officer and shareholder of Amgen and is a scientific co-founder and shareholder of Tenaya Therapeutics. T.A.M. received funding from Italfarmaco for an unrelated project. K.S.P. is a shareholder of Tenaya Therapeutics.